Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Xin Fu

Showing results (111-120 of 337) with videos related to

Pageof 34
Sort By:
Trends in Immunology|December 9, 2008
Do adaptive immune cells suppress or activate innate immunity?Jie Zhao, Xuanming Yang, Sogyong L Auh, et al.
International Immunology|July 29, 2003
Membrane lymphotoxin is required for resistance to Theiler's virus infectionXiaoqi Lin, Xiaoxing Ma, Moses Rodriguez, et al.
Nature Medicine|September 25, 2007
Adaptive immune cells temper initial innate responsesKwang Dong Kim, Jie Zhao, Sogyong Auh, et al.
Nature Communications|May 14, 2021
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapyEric J Hsu, Xuezhi Cao, Benjamin Moon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in miceGuilian Xu, Dong Liu, Yijun Fan, et al.
Cancer Research|May 13, 2010
Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionShreya Kanodia, Diane M Da Silva, Tigran Karamanukyan, et al.
The Journal of Clinical Investigation|January 3, 2014
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in miceLiufu Deng, Hua Liang, Byron Burnette, et al.
Cell Host & Microbe|July 11, 2014
A BTLA-mediated bait and switch strategy permits Listeria expansion in CD8α(+) DCs to promote long-term T cell responsesXuanming Yang, Xunmin Zhang, Yonglian Sun, et al.
The Journal of Clinical Investigation|February 1, 2022
Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicityZhenhua Ren, Anli Zhang, Zhichen Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitisYonglian Sun, Xiaoqi Lin, Helen M Chen, et al.
Pageof 34

Showing results (111-120 of 337) with videos related to

Sort By:
Pageof 34
Trends in Immunology|December 9, 2008
Do adaptive immune cells suppress or activate innate immunity?Jie Zhao, Xuanming Yang, Sogyong L Auh, et al.
International Immunology|July 29, 2003
Membrane lymphotoxin is required for resistance to Theiler's virus infectionXiaoqi Lin, Xiaoxing Ma, Moses Rodriguez, et al.
Nature Medicine|September 25, 2007
Adaptive immune cells temper initial innate responsesKwang Dong Kim, Jie Zhao, Sogyong Auh, et al.
Nature Communications|May 14, 2021
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapyEric J Hsu, Xuezhi Cao, Benjamin Moon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in miceGuilian Xu, Dong Liu, Yijun Fan, et al.
Cancer Research|May 13, 2010
Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionShreya Kanodia, Diane M Da Silva, Tigran Karamanukyan, et al.
The Journal of Clinical Investigation|January 3, 2014
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in miceLiufu Deng, Hua Liang, Byron Burnette, et al.
Cell Host & Microbe|July 11, 2014
A BTLA-mediated bait and switch strategy permits Listeria expansion in CD8α(+) DCs to promote long-term T cell responsesXuanming Yang, Xunmin Zhang, Yonglian Sun, et al.
The Journal of Clinical Investigation|February 1, 2022
Selective delivery of low-affinity IL-2 to PD-1+ T cells rejuvenates antitumor immunity with reduced toxicityZhenhua Ren, Anli Zhang, Zhichen Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitisYonglian Sun, Xiaoqi Lin, Helen M Chen, et al.
Pageof 34